SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM. The company filed the application on 16 August with SGX Regco.
該公司於8月16日向新加坡證券交易所註冊公司提交了申請。
The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing.
證券交易所的一份文件顯示，新加坡先進醫學研究所控股有限公司（SaM Holdings）申請延期提交其2024財年（2024財年）收益業績的申請已獲得新加坡交易監管（SGX Regco）的批准。
This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December.
這允許該公司延長兩個月，以便在10月29日之前發佈其2024財年業績，並在12月31日之前召開年度股東大會（AGM）。
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM.
他們還獲准在 12 月 16 日之前將 AR2024 的發行期限延長兩個月，即股東周年大會日期的至少 14 天。
Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.
此外，預計該公司還將向會計和公司監管局（ACRA）申請延期2024年股東大會。
